Langconoy, Wilfredo L.

HRN: 21-51-49  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/30/2022
07/07/2022
IVTT
750mg
Q24
Increasing WBC Trend; Pustular Discharges; Pulmonary Infiltrates
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: